Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCurrent Gene Therapy is a journal in gene therapy with ISSN 1566-5232 (print) and 1875-5631 (online). It has an Impact Factor of 3.3, is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed, and publishes Volume 26 in 2026. The journal offers online manuscript submission and includes both subscription content and open access articles.
Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Current Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Systematic Reviews
Meta-Analyses
Research Articles
Randomized Drug Clinical Trial Studies
Short Communications
Letters
Case Reports
Recent Publications
Efficacy and Safety of Immune Checkpoint Inhibitors for Recurrent or Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis
Yuanyuan Li, Songyi Wang, Yirui Mai, Zhixi You, Yu Wang, Jiake Wang, Ye Lei
Targeting FUNDC1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Suppressing Mitochondrial Function
Weinan Yao, Dong Guo, Xueyuan Zhang, Xingyu Du, Wenbin Shen, Shuchai Zhu
The TRH-TRHR Axis Acts as a Metabolic Checkpoint for Ammonia Tolerance in AML: Therapeutic Targeting via Imiquimod and Itraconazole
Yan Wang, Xinhui Qiu, Weiwei Liu, Zhixiang Lei, Zheying Wang, Xiaoyu Zhang, Hongxing Wang, Hongchun Wang
ZBTB33/RBM15 Axis Upregulates MACC1 to Promote the Malignant Progression of Colorectal Cancer
Lichun Wang, Bin Guo, Xueping Jiao, Quanmao Zhang, Sheng Gao
Integration of Single-Cell Transcriptomics and Network-Based Machine Learning Identifies Bone Marrow Mesenchymal Stem Cell-Associated Candidate Biomarkers and Exploratory Immune Correlates in Osteoarthritis
Hanyu Wang, Zhikang Chen, Shikai Chen, Honglin Pi, Qianqian Liang, Li Wang
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of the final approved galley proofs and 10 weeks from first receipt of the manuscript to online publication, subject to acceptance and author revisions within one week. Revised papers are usually requested within 15 days, with revision time varying from 1 to 4 weeks. Proofs should be returned within 48 hours.
Reformat to Current Gene Therapy using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to Current Gene Therapy using Livewrite PremiumWhat are the publication costs?
Publication charges are US $690 for research articles, US $190 for short communications/letters, and US $290 for review articles. Optional Gold Open Access costs US $3633 per article for general submissions and US $1900 for thematic issues.
Reformat to Current Gene Therapy using Livewrite Premium